Doctors test if lifesaving drugs reach the right spots in severe infections
NCT ID NCT02805049
Summary
This study aimed to understand how two antifungal drugs (caspofungin and micafungin) move through the bodies of critically ill patients. It involved 24 adults in intensive care with a severe abdominal infection (peritonitis) that led to septic shock. Researchers measured drug levels in the blood and abdomen to see if standard doses were effective for these very sick patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, 30029, France
-
Royal Brisbane Women's Hospital
Herston, 4029, Australia
Conditions
Explore the condition pages connected to this study.